Behavioral Health Report – Q3 2021 Acquisition Activity and Outlook
Behavioral Health Deals Continue at a Strong Pace. Activity Suggests a Surge of Acquisitions in Q4.
The third quarter of 2021 delivered thirty-three reported behavioral health acquisitions, continuing a strong pace of deal activity over the past year. Mental Health and Addiction treatment continues to be at the forefront of consolidation.
ENT & Allergy Report – Q2 2021 Acquisition Activity and Outlook
Quiet Quarter for ENT & Allergy Practices Acquisitions. Expect Increasing Opportunity for Large Practice Sellers
Although we did not track any reported transactions in Q2, the first half of 2021 delivered three reported ENT practice acquisitions.
Dermatology Report – Q2 2021 Acquisition Activity and Outlook
Core Dermatology Buyers Remain Active in 2021. Window of Opportunity May Be Starting to Close for Smaller Practices
The second quarter of 2021 delivered six reported dermatology practice acquisitions.
Behavioral Health Report – Q2 2021 Acquisition Activity and Outlook
Transaction Volume Remains High Throughout Behavioral Health
The second quarter of 2021 delivered thirty-four reported behavioral health transactions, continuing a strong consolidation surge within the industry. We generally expect high deal flow throughout 2021, supported by increasing private equity interest, a favorable government, and a seller pool that is ready to transact.
Buyer Spotlight: EyeSouth Partners
EyeSouth is One of the Most Active Ophthalmology Practice Management Companies with 23 Acquisitions Since 2017
We profile investors to provide our clients with an important understanding of the types of private equity firms, independent investors, and family offices active in the healthcare verticals we work in every day. Although it is not feasible to create case studies for every investor, we profile those that represent the most active practices common in today’s acquisition market.
FOCUS Investment Banking Represents Microconsult Inc. in Sale to Certified Laboratories
Washington, DC, (June 4, 2021) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Microconsult, Inc., a Carrollton, Texas-based industry leader in cosmetic, supplement and personal care product testing, has been acquired by Certified Laboratories, a Melville, New York-based operator of food, supplements, cosmetic, and personal care laboratories. FOCUS represented Microconsult in this transaction.
Microconsult, Inc. has been acquired by Certified Group
Washington, DC, (June 4, 2021) – FOCUS Investment Banking (“FOCUS”), a ...